Taysha Gene Therapies
Price & Volume
Stats
See more52W Range | $1.05-$6.02 |
Market Cap | $1.1B |
Shares Short | 46M |
Financials
See moreRevenue (12 Mos) | $9.7M |
Revenue Growth (YoY) | 171.3% |
Gross Profit (12 Mos) | $9.7M |
Diluted EPS | -$0.34 |
News
See moreYahoo Finance • 8 days ago
Structure Therapeutics Slides 28% This Year as $6 Million Stake Emerges
Yahoo Finance • 12 days ago
Taysha Gene Therapies Q4 Earnings Call Highlights
Yahoo Finance • 12 days ago
Taysha Gene Therapies GAAP EPS of -$0.34 beats by $0.02, revenue of $9.77M beats by $3.47M
Yahoo Finance • 12 days ago
Taysha Gene Therapies Reports Full-Year 2025 Financial Results and Provides Corporate Update
About
CEO | Mr. Sean P. Nolan |
CFO | Mr. Kamran Alam CPA, M.B.A. |
Address | 3000 Pegasus Park Drive, Dallas, TX, United States, 75247 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 99 |
